For instance, BIRC3 genetic inactivation due to deletions or point mutations is consistently associated to shorter progression free survival and poor prognosis in chronic lymphocytic leukemia patients. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.